(Corrects to say price caps extended to 2 drugs rather than 39 in the headline, 1st and 2nd paragraph, corrects to say more than 500 drugs listed in the price control list in 2nd and 4th paragaphs)
MUMBAI (Reuters) - India has extended price caps to two commonly used antibiotics, in the government's latest effort to improve affordability of medicines.
A notice posted on the National Pharmaceutical Pricing Authority (NPPA) website late on Wednesday detailed the two antibiotics, which extend a price control list that already includes more than 500 medicines.
(Reporting by Zeba Siddiqui in Mumbai; Editing by Clara Ferreira Marques)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app